Option Care Health (OPCH) Announces Secondary Offering of 15M Shares of Common Stock
Get Alerts OPCH Hot Sheet
Join SI Premium – FREE
Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 15,000,000 shares of the Company’s common stock in an underwritten public offering. The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to 2,250,000 additional shares of common stock. The Company will not receive any proceeds from the offering.
This sale of shares represents approximately 8.3% of the current shares outstanding (or9.6% assuming full exercise of the underwriter’s option to purchase additional shares). Upon completion of this offering, the Selling Stockholder’s interest in the Company will be reduced to 29.3% of the outstanding shares (or 28.1% assuming full exercise of the underwriter’s option to purchase additional shares), from the current 37.7%.
Consistent with the June 2021 secondary offering, Madison Dearborn Partners and Walgreen Co., a wholly owned subsidiary of Walgreens Boots Alliance, Inc. (“Walgreens”), have agreed in principle to allocate all of the Selling Stockholder’s offering proceeds to affiliates of Madison Dearborn Partners and other equityholders of the Selling Stockholder. As a result, Walgreens will maintain its approximately 21% indirect financial interest in Option Care Health following this offering.
Goldman Sachs & Co. LLC is acting as the sole underwriter for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Financial Corp. (TFC) shareholders elect Laurence Stein to board of directors
- Goldman Sachs Comments on Sherwin-Williams (SHW) Earnings
- Goldman Sachs First Take on Tata Consumer Products (TGBL:IN) Earnings
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Goldman Sachs, Madison Dearborn Partners, S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!